​

Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Neurocrine Biosciences Ownership Summary


Neurocrine Biosciences is owned by 101.01% institutional investors, 1.06% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.71% of NBIX shares. Dodge & Cox Stock I is the top mutual fund, with 3.84% of its assets in Neurocrine Biosciences shares.

NBIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeurocrine Biosciences101.01%1.06%-2.07%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de14.86M14.71%$2.11B
Blackrock14.19M14.22%$1.95B
Vanguard group9.70M9.76%$1.38B
Dodge & cox5.50M5.45%$780.77M
Jpmorgan chase5.29M5.24%$733.01M
Vanguard portfolio management5.06M5.01%$717.72M
State street4.81M4.76%$681.96M
Vanguard capital management4.58M4.54%$649.74M
Aqr capital management3.82M3.80%$643.47M
Renaissance2.30M2.28%$326.33M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp116.53K11.04%$19.64M
Vestal point capital, lp1.88M7.40%$316.85M
Pko bp bankowy universal pension society jsc170.80K7.13%$24.23M
Pfm health sciences, lp213.41K3.09%$35.97M
Avidity partners management lp220.40K2.95%$30.08M
Iron triangle partners lp131.39K2.62%$18.44M
Science & technology partners79.72K2.26%$13.44M
Capital impact advisors184.03K2.25%$26.10M
Seizert capital partners358.82K2.21%$50.89M
Braidwell lp336.17K2.10%$56.66M

Top Buyers

HolderShares% AssetsChange
Abrdn1.18M0.16%1.16M
Blackrock funding, inc. /de14.86M0.03%1.14M
Norges bank973.88K0.02%973.88K
Vestal point capital, lp1.88M7.40%630.00K
Thrivent financial for lutherans824.03K0.19%526.74K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp34.64K0.00%-1.35M
Millennium management11.59K0.00%-1.24M
Aqr capital management3.82M0.22%-1.12M
Jpmorgan chase5.29M0.04%-1.11M
Two sigma investments, lp2.08M0.25%-984.31K

New Positions

HolderShares% AssetsChangeValue
Norges bank973.88K0.02%973.88K$164.13M
Axa investment managers323.90K0.12%323.90K$45.47M
Jupiter asset management252.03K0.17%252.03K$35.75M
Capital impact advisors184.03K2.25%184.03K$26.10M
Wilshire advisors166.63K0.05%166.63K$23.63M

Sold Out

HolderChange
Wealthtrak capital management-1.00
Nemes rush group-1.00
New millennium group-1.00
Buck wealth strategies-1.00
Comprehensive financial planning, inc./pa-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20267859.48%101,517,6861.53%1011.02%45817.14%2243.70%
Mar 31, 2026694-6.72%98,421,444-0.74%980.99%373-9.69%211-3.65%
Dec 31, 2025286-56.60%23,096,413-76.21%230.24%161-53.47%78-63.72%
Sep 30, 2025313-46.40%27,003,435-70.64%270.32%165-45.54%95-55.40%
Jun 30, 20255880.17%97,956,5484.05%981.11%30220.32%215-15.02%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I3.91M3.84%-58.20K
iShares Core S&P Mid-Cap ETF3.65M3.61%1.96K
Vanguard US Total Market Shares ETF3.20M3.21%2.53K
Vanguard MStar Total Stk Mkt Idx Invest3.23M3.18%35.09K
Vanguard Total Stock Mkt Idx Inv3.19M3.18%-1.38K
Vanguard Morn Total Stk Mkt Idx Investor3.19M3.18%-1.38K
Vanguard Small Cap Index2.29M2.25%-25.44K
BB Biotech AG Ord1.76M1.75%-60.00K
Vanguard Morn Small Cap Growth Index Inv1.33M1.32%32.38K
Vanguard Small Cap Growth Index Inv1.33M1.32%32.38K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 02, 2026MORROW GEORGE J-Sell$275.45K
Nov 03, 2026MORROW GEORGE J-Sell$16.20K
Nov 03, 2026MORROW GEORGE J-Sell$98.22K
Nov 03, 2026MORROW GEORGE J-Sell$15.82K
Nov 03, 2026MORROW GEORGE J-Sell$201.97K

Insider Transactions Trends


DateBuySell
2026 Q4-12
2026 Q3-9
2026 Q2-21
2026 Q1-2
2025 Q4-8

NBIX Ownership FAQ


Who Owns Neurocrine Biosciences?

Neurocrine Biosciences shareholders are primarily institutional investors at 101.01%, followed by 1.06% insiders and -2.07% retail investors. The average institutional ownership in Neurocrine Biosciences's industry, Biotech Stocks , is 385.89%, which Neurocrine Biosciences falls below.

Who owns the most shares of Neurocrine Biosciences?

Neurocrine Biosciences’s largest shareholders are Blackrock funding, inc. /de (14.86M shares, 14.71%), Blackrock (14.19M shares, 14.22%), and Vanguard group (9.7M shares, 9.76%). Together, they hold 38.69% of Neurocrine Biosciences’s total shares outstanding.

Does Blackrock own Neurocrine Biosciences?

Yes, BlackRock owns 14.22% of Neurocrine Biosciences, totaling 14.19M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.95B$. In the last quarter, BlackRock increased its holdings by 429.74K shares, a 3.12% change.

Who is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested, with 11.04% of its assets in 116.53K Neurocrine Biosciences shares, valued at 19.64M$.

Who is the top mutual fund holder of Neurocrine Biosciences shares?

Dodge & Cox Stock I is the top mutual fund holder of Neurocrine Biosciences shares, with 3.84% of its total shares outstanding invested in 3.91M Neurocrine Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools